Aesthetic Medicine

LATEST NEWS

Many Certified Cosmetic Surgeons Not Trained in Surgical Discipline

Many physicians advertising themselves as board-certified cosmetic surgeons are not as qualified as plastic surgeons.

Studies Claiming Bakuchiol New “Skincare Hero” Have Major Methodologic Flaws

By

Emily Pond

Manufacturer’s use of clinical trial data to support claims that bakuchiol possesses anti-aging properties is critically appraised.

Treatment Options for Cutaneous Viral Warts in Children

By

Emily Pond

The current literature on the methods, efficacy, and adverse event profile of common treatment modalities for cutaneous viral warts in children is reviewed.

Cosmetic Camouflage for Permanent Facial Lesions in SLE Associated With Improved Quality of Life

By

Emily Pond

Researchers investigated the effect of cosmetic camouflage on health-related quality of life in women with SLE and permanent facial skin damage.

Zoom Meetings Driving Surge in Face-Lifts

People whose only contact with the outside world is Zoom are taking a close look at themselves and flocking to plastic surgeons for face-lifts and eye lifts.

Botulinum Toxin Type A Effective for Treatment of Hypertrophic Scars

By

Colby Stong

Significant clinical and cosmetic improvement was seen after treatment with botulinum toxin type A.

Botox Injections May Ease Depression

Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression.

Avoiding Tattooing Risks

By

Brandon May

Dermatologists play a key role in detecting patients at risk for complications from tattooing.

Upneeq Approved for Acquired Blepharoptosis

By

Brian Park, PharmD

The FDA has approved Upneeq™ (oxymetazoline hydrochloride ophthalmic solution; Osmotica) for the treatment of acquired blepharoptosis in adults.

FDA Approves Qwo to Treat Moderate to Severe Cellulite

By

Brian Park, PharmD

Results from both studies showed treatment with Qwo was associated with greater reductions in cellulite severity compared with placebo as measured by CR-PCSS and PR-PCSS scales at day 71.